During the past decade, Panthera Biopartners Sheffield conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Panthera Biopartners Sheffield" are "Alzheimers Disease" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Panthera Biopartners Sheffield" in a lesser frequency.

Most popular intervention types in "Panthera Biopartners Sheffield" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (1 trials), "Placebo" (1 trials), "Placebo comparator dosing" (1 trials), "Rimegepant 75mg daily dosing" (1 trials) and "Rimegepant 75mg every other day dosing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Panthera Biopartners Sheffield" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Panthera Biopartners Sheffield". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Panthera Biopartners Sheffield, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Panthera Biopartners Sheffield, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".